Home›Industries›Biotech & Pharma›2024

Biotech startup funding in 2024

Every new Form D round of US startups in Biotech & Pharma first filed in 2024.

468 biotech startups filed a new Form D round in 2024. Together they reported $10.96B sold in 515 rounds. The median round was $5.0M.

Companies
468
with a new round in 2024
Reported sold
$10.96B
515 rounds
Median round
$5.0M
rounds with an amount
Largest round
$421.7M
Treeline Biosciences, Inc.

New funding by month

Amount reported sold in new Form D rounds, by the month each round was first filed. Hover a bar for the number of rounds.
Show as table
MonthRoundsReported sold
December 202451$565.0M
November 202437$720.1M
October 202449$1.22B
September 202433$1.01B
August 202441$837.0M
July 202445$1.33B
June 202440$439.1M
May 202454$1.15B
April 202441$1.05B
March 202444$1.13B
February 202434$741.7M
January 202446$741.7M

July 2024 was the largest month, at $1.33B in 45 rounds.

Biotech companies that raised the most in 2024

#CompanyReported soldRoundsFocusLatest round
1$421.7M1TherapeuticsOct 17, 2024
2$412.9M2TherapeuticsApr 3, 2024
3
TrialSpark, Inc.New York, NY
$372.2M1TherapeuticsJul 2, 2024
4
Arsenal Biosciences, Inc.South San Francisco, CA
$325.3M1Cell and gene therapySep 4, 2024
5$260.4M1TherapeuticsJul 24, 2024
6$226.9M3Cell and gene therapyMar 20, 2024
7$225.8M1TherapeuticsOct 31, 2024
8
Metsera, Inc.New York, NY
$214.9M1TherapeuticsNov 20, 2024
9$206.2M1TherapeuticsSep 13, 2024
10$200.1M1TherapeuticsMay 14, 2024
11
TheRas, Inc.Palo Alto, CA
$200.0M1TherapeuticsMay 15, 2024
12
BioAge Labs, Inc.Richmond, CA
$194.3M1TherapeuticsFeb 13, 2024
13$175.0M1TherapeuticsOct 2, 2024
14
Endo, Inc.Malvern, PA
$170.5M1TherapeuticsMar 21, 2024
15$158.3M1TherapeuticsApr 17, 2024
16
Cellanome, Inc.Foster City, CA
$149.9M1Life science tools and servicesJan 29, 2024
17
Syncromune, Inc.Fort Lauderdale, FL
$144.8M1TherapeuticsDec 17, 2024
18
NGM Bio Holdings, Inc.South San Francisco, CA
$142.0M1TherapeuticsJul 17, 2024
19$132.5M1TherapeuticsMay 3, 2024
20
Rivus Pharmaceuticals, Inc.Charlottesville, VA
$131.9M2TherapeuticsSep 17, 2024
21
Alumis Inc.South San Francisco, CA
$129.4M1TherapeuticsMar 11, 2024
22
Alzheon, Inc.Framingham, MA
$126.2M1TherapeuticsMar 12, 2024
23$125.6M1TherapeuticsJul 16, 2024
24
Neurona Therapeutics, Inc.South San Francisco, CA
$119.9M1Cell and gene therapyFeb 13, 2024
25$119.8M1TherapeuticsJan 25, 2024

Largest rounds of 2024

All industries →
CompanyFocusLocationAmount soldInvestorsFiling
Treeline Biosciences, Inc.Repeat raise · October 17, 2024
TherapeuticsWatertown, MA$421.7M43Form D ↗
TrialSpark, Inc.First Form D · July 2, 2024
TherapeuticsNew York, NY$372.2M16Form D ↗
Mirador Therapeutics, Inc.Repeat raise · April 3, 2024
TherapeuticsSan Diego, CA$332.9M31Form D ↗
Arsenal Biosciences, Inc.Repeat raise · September 4, 2024
Cell and gene therapySouth San Francisco, CA$325.3M26Form D ↗
Cardurion Pharmaceuticals, Inc.Repeat raise · July 24, 2024
TherapeuticsBurlington, MA$260.4M19Form D ↗
Seaport Therapeutics, Inc.First Form D · October 31, 2024
TherapeuticsBoston, MA$225.8M33Form D ↗
Metsera, Inc.First Form D · November 20, 2024
TherapeuticsNew York, NY$214.9M38Form D ↗
Candid Therapeutics, Inc.First Form D · September 13, 2024
TherapeuticsSan Diego, CA$206.2M33Form D ↗
Zenas BioPharma, Inc.Repeat raise · May 14, 2024
TherapeuticsWaltham, MA$200.1M26Form D ↗
TheRas, Inc.First Form D · May 15, 2024
TherapeuticsPalo Alto, CA$200.0M15Form D ↗

Where these companies are

Every Biotech & Pharma round of 2024 515

All industries →
How this page is built
  • Which rounds. New Form D offerings of US startups in Biotech & Pharma first filed in 2024, dated by that first filing. Later amendments update an amount; they are not new rounds.
  • Ranking. By the total reported sold across a company's rounds of 2024. Two SEC filers of one company, such as a holding company and its operating company, count as one company, under the name on the newest filing.
  • Left out. Public companies, companies based outside the US, and mergers or spin-offs. Some companies raise money without filing a Form D.